Viewing Study NCT00288704

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:06 PM
Ignite Modification Date: 2026-03-10 @ 8:06 PM
Study NCT ID: NCT00288704
Status: COMPLETED
Last Update Posted: 2011-12-06
First Post: 2006-02-06
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
Sponsor: Regeneron Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Familial Cold Autoinflammatory Syndrome (FCAS) View
None Familial Cold Urticaria View
None Muckle-Wells Syndrome (MWS) View
None Genetic Diseases, Inborn View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Familial Cold Autoinflammatory Syndrome (FCAS) View
None Muckle-Wells Syndrome (MWS) View
None CIAS1 View
None NLRP-3 View
None PYPAF1 View
None Cryopyrin View
None CAPS View
None Interleukin-1 View